ロード中...
Cancer immunotherapy products: Regulatory aspects in the European Union
Active immunotherapy products (widely known as “cancer vaccines”) are products intended to stimulate an immune response to mediate tumor destruction or reduce the progression of disease in patients where cancer has been diagnosed. Some quality attributes of these products are very difficult to chara...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3579920/ https://ncbi.nlm.nih.gov/pubmed/22863755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.21142 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|